CD40–CD40L: Linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD40–CD40L: Linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications
Authors
Keywords
-
Journal
Diabetes & Vascular Disease Research
Volume 10, Issue 2, Pages 115-122
Publisher
SAGE Publications
Online
2012-09-11
DOI
10.1177/1479164112455817
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute Suppression of Circulating sCD40L During Hyperglycemia and Euglycemic-Hyperinsulinemia in Healthy Young Males
- (2016) Stacy R. Oliver et al. JOURNAL OF INVESTIGATIVE MEDICINE
- CD40L Deficiency Ameliorates Adipose Tissue Inflammation and Metabolic Manifestations of Obesity in Mice
- (2011) Marjorie Poggi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Inflammatory links between obesity and metabolic disease
- (2011) Carey N. Lumeng et al. JOURNAL OF CLINICAL INVESTIGATION
- The immune system in atherosclerosis
- (2011) Göran K Hansson et al. NATURE IMMUNOLOGY
- From Atherosclerosis to Acute Coronary Syndromes: The Role of Soluble CD40 Ligand
- (2011) Dimitris Tousoulis et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Glycemic Control and Complications in Type 2 Diabetes Mellitus
- (2010) Mark Stolar AMERICAN JOURNAL OF MEDICINE
- Enhanced Levels of Soluble CD40 Ligand Exacerbate Platelet Aggregation and Thrombus Formation Through a CD40-Dependent Tumor Necrosis Factor Receptor–Associated Factor-2/Rac1/p38 Mitogen-Activated Protein Kinase Signaling Pathway
- (2010) Daniel Yacoub et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis
- (2010) D. Lievens et al. BLOOD
- Soluble CD40 Ligand Impairs the Function of Peripheral Blood Angiogenic Outgrowth Cells and Increases Neointimal Formation After Arterial Injury
- (2010) Mihail Hristov et al. CIRCULATION
- Endoplasmic Reticulum Stress and Inflammation in Obesity and Diabetes
- (2010) Sarah Hummasti et al. CIRCULATION RESEARCH
- Biomarkers in Fasting Serum to Estimate Glucose Tolerance, Insulin Sensitivity, and Insulin Secretion
- (2010) A. B. Goldfine et al. CLINICAL CHEMISTRY
- The importance of glycated haemoglobin (HbA1c) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes
- (2010) Pan Chang Yu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The global burden of diabetes and its complications: an emerging pandemic
- (2010) Dieren Susan van et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- Beyond Hemoglobin A1c—Need for Additional Markers of Risk for Diabetic Microvascular Complications
- (2010) Irl B. Hirsch JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile
- (2010) Esther Lutgens et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intensive glycemic control and cardiovascular disease: an update
- (2010) Aparna Brown et al. Nature Reviews Cardiology
- Soluble CD40 ligand is elevated in Type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function
- (2010) Maria Lajer et al. PLATELETS
- CD40L induces inflammation and adipogenesis in adipose cells – a potential link between metabolic and cardiovascular disease
- (2010) Isabel Platzer et al. THROMBOSIS AND HAEMOSTASIS
- The role of CD154 in haematopoietic development
- (2010) Tom Seijkens et al. THROMBOSIS AND HAEMOSTASIS
- Glucose Control and Cardiovascular Disease: Is it important? No
- (2009) I. Conget et al. DIABETES CARE
- The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes
- (2009) M. Poggi et al. DIABETOLOGIA
- Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications
- (2009) Serkan Yener et al. MEDICAL PRINCIPLES AND PRACTICE
- CD40 and autoimmunity: The dark side of a great activator
- (2009) Anna L. Peters et al. SEMINARS IN IMMUNOLOGY
- The immunobiology of CD154–CD40–TRAF interactions in atherosclerosis
- (2009) David Engel et al. SEMINARS IN IMMUNOLOGY
- Soluble CD40 ligand induces human coronary artery smooth muscle cells proliferation and migration
- (2009) Hong Chai et al. SURGERY
- Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients
- (2009) J. B. Muhlestein THROMBOSIS AND HAEMOSTASIS
- CD40 activation in human pancreatic islets and ductal cells
- (2008) D. Klein et al. DIABETOLOGIA
- Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST
- (2008) Luis M. Blanco-Colio et al. KIDNEY INTERNATIONAL
- Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
- (2008) Theodore Mazzone et al. LANCET
- Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome. Soluble CD40 ligand and diurnal variation
- (2008) Alberto Dominguez-Rodriguez et al. THROMBOSIS RESEARCH
- Correlation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabetes mellitus
- (2007) Shosaku Nomura et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started